6 reports

PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW ## COMPETITIVE ANALYSIS ## MARKET TRENDS ## MARKET DEVELOPMENTS ## PROCEDURE NUMBERS ## PROCEDURE CODES INVESTIGATED ## MARKETS INCLUDED ## KEY REPORT UPDATES ## VERSION HISTORY ## RESEARCH METHODOLOGY ## Step ##: Pr

  • Transplantation
  • United States
  • Market Shares
  • XENOGRAFT IMPLANT - PERIPHERAL VASCULAR DISEASE PRODUCT OVERVIEW
  • CARDIOVESSEL - PRODUCT STATUS

One unit refers to one vascular graft.

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Transplantation
  • United States
  • Humacyte, Inc.
  • AMPLATZER PERIPHERAL VASCULAR GRAFT PRODUCT OVERVIEW
  • AMPLATZER TAA VASCULAR GRAFT - PRODUCT STATUS

Jude Medical LLC Amplatzer Peripheral Vascular Graft Inactive St.

  • Clinical Trial
  • Interventional Cardiology Device
  • Medical Device
  • Transplantation
  • Endologix, Inc.
  • 11.3 C. R. BARD

The company' s Vascular business has two units-Bard Electrophysiology Division and Bard Peripheral Vascular Inc., the latter is engaged in the development of peripheral vascular devices and dilatation catheters for percutaneous transluminal a

  • Transplantation
  • North America
  • United States
  • Forecast
  • Medtronic, Inc.
  • Endogenous Tissue Restoration (ETR) Cardiovascular Graft - Product Status

Xeltis' restorative pulmonary valve is an investigational device not approved for use in the United States.

  • Clinical Trial
  • Drug Development
  • Transplantation
  • United States
  • Product Initiative
  • AMPLATZER PERIPHERAL VASCULAR GRAFT - PRODUCT STATUS
  • AMPLATZER AAA VASCULAR GRAFT - PRODUCT STATUS

The latest OPTIS System offers physicians an efficient way to optimize PCI procedures for the treatment of vascular disease by combining diagnostic tools designed to improve patient outcomes into one portable device.

  • Transplantation
  • United States
  • Jude Medical, Inc.
  • Nanostim, Inc.
  • Thoratec Corporation